Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Varicose Ulcer | 24 | 2021 | 55 | 5.460 |
Why?
|
Varicose Veins | 22 | 2020 | 157 | 5.300 |
Why?
|
Venous Insufficiency | 20 | 2024 | 108 | 5.220 |
Why?
|
Glycosaminoglycans | 7 | 2024 | 611 | 2.460 |
Why?
|
Vena Cava, Inferior | 10 | 2020 | 463 | 2.240 |
Why?
|
Vasodilation | 9 | 2019 | 968 | 1.810 |
Why?
|
Vasoconstriction | 10 | 2020 | 594 | 1.790 |
Why?
|
Aortic Aneurysm, Abdominal | 13 | 2022 | 1252 | 1.260 |
Why?
|
E-Selectin | 2 | 2022 | 578 | 1.240 |
Why?
|
Saphenous Vein | 5 | 2024 | 519 | 1.230 |
Why?
|
Vasoconstrictor Agents | 10 | 2020 | 657 | 1.140 |
Why?
|
Femoral Artery | 6 | 2016 | 829 | 1.130 |
Why?
|
Venous Thrombosis | 6 | 2022 | 1317 | 1.120 |
Why?
|
Matrix Metalloproteinase 2 | 5 | 2020 | 462 | 1.120 |
Why?
|
Wound Healing | 11 | 2017 | 2813 | 1.090 |
Why?
|
Matrix Metalloproteinase 9 | 4 | 2024 | 633 | 1.080 |
Why?
|
Matrix Metalloproteinases | 7 | 2017 | 393 | 1.070 |
Why?
|
Leg | 5 | 2021 | 1088 | 1.070 |
Why?
|
Veins | 5 | 2017 | 768 | 0.990 |
Why?
|
Leg Ulcer | 2 | 2016 | 71 | 0.990 |
Why?
|
Blood Vessel Prosthesis Implantation | 10 | 2022 | 1459 | 0.980 |
Why?
|
Iliac Vein | 3 | 2023 | 70 | 0.860 |
Why?
|
Muscle, Smooth, Vascular | 8 | 2016 | 1493 | 0.850 |
Why?
|
Vascular Diseases | 5 | 2023 | 1161 | 0.800 |
Why?
|
Fibroblasts | 10 | 2009 | 4177 | 0.790 |
Why?
|
Arterial Occlusive Diseases | 5 | 2016 | 746 | 0.790 |
Why?
|
Lower Extremity | 8 | 2023 | 1218 | 0.740 |
Why?
|
Aneurysm | 2 | 2017 | 343 | 0.730 |
Why?
|
Endothelium, Vascular | 5 | 2019 | 4427 | 0.720 |
Why?
|
Vascular Surgical Procedures | 10 | 2022 | 1515 | 0.680 |
Why?
|
Chronic Disease | 23 | 2024 | 9379 | 0.650 |
Why?
|
Nitric Oxide | 5 | 2019 | 2144 | 0.650 |
Why?
|
Stockings, Compression | 4 | 2020 | 36 | 0.620 |
Why?
|
Leukocytes | 4 | 2017 | 2030 | 0.600 |
Why?
|
Endovascular Procedures | 8 | 2024 | 2215 | 0.590 |
Why?
|
Endarterectomy, Carotid | 2 | 2022 | 557 | 0.570 |
Why?
|
Peripheral Vascular Diseases | 4 | 2010 | 489 | 0.540 |
Why?
|
Thrombophlebitis | 3 | 2014 | 289 | 0.540 |
Why?
|
Phenylephrine | 8 | 2016 | 293 | 0.520 |
Why?
|
Intermittent Claudication | 4 | 2016 | 305 | 0.500 |
Why?
|
Glycocalyx | 1 | 2016 | 98 | 0.480 |
Why?
|
Portal Vein | 1 | 2017 | 432 | 0.480 |
Why?
|
Carotid Stenosis | 1 | 2022 | 862 | 0.470 |
Why?
|
Ultrasonography, Doppler, Duplex | 2 | 2013 | 198 | 0.460 |
Why?
|
Anti-Inflammatory Agents | 2 | 2014 | 1813 | 0.460 |
Why?
|
Iliac Artery | 3 | 2016 | 344 | 0.440 |
Why?
|
Colony-Stimulating Factors | 1 | 2014 | 218 | 0.440 |
Why?
|
Anticoagulants | 3 | 2020 | 4843 | 0.430 |
Why?
|
Potassium Chloride | 6 | 2011 | 229 | 0.420 |
Why?
|
Tissue Inhibitor of Metalloproteinases | 2 | 2016 | 97 | 0.420 |
Why?
|
Drug-Eluting Stents | 1 | 2018 | 681 | 0.400 |
Why?
|
Calcium Signaling | 3 | 2011 | 739 | 0.390 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channels | 1 | 2011 | 36 | 0.390 |
Why?
|
Aneurysm, Infected | 1 | 2012 | 81 | 0.390 |
Why?
|
Venous Pressure | 2 | 2008 | 55 | 0.380 |
Why?
|
Escin | 1 | 2011 | 2 | 0.380 |
Why?
|
Methylenetetrahydrofolate Dehydrogenase (NADP) | 1 | 2011 | 18 | 0.380 |
Why?
|
Cardiovascular Agents | 3 | 2014 | 849 | 0.380 |
Why?
|
Aneurysm, Ruptured | 1 | 2016 | 462 | 0.380 |
Why?
|
Rats, Sprague-Dawley | 9 | 2020 | 8199 | 0.370 |
Why?
|
Vasodilator Agents | 5 | 2011 | 990 | 0.370 |
Why?
|
Endarterectomy | 1 | 2011 | 196 | 0.370 |
Why?
|
Heart Valve Diseases | 1 | 2018 | 1030 | 0.360 |
Why?
|
Biological Factors | 1 | 2011 | 158 | 0.360 |
Why?
|
Microcirculation | 2 | 2015 | 1282 | 0.360 |
Why?
|
Aortic Diseases | 4 | 2016 | 741 | 0.350 |
Why?
|
Axillary Artery | 2 | 2016 | 48 | 0.340 |
Why?
|
Dose-Response Relationship, Drug | 8 | 2019 | 10776 | 0.330 |
Why?
|
Aneurysm, False | 2 | 2011 | 263 | 0.320 |
Why?
|
Vascular Neoplasms | 1 | 2011 | 167 | 0.320 |
Why?
|
Angioplasty | 1 | 2011 | 357 | 0.320 |
Why?
|
Skin | 4 | 2013 | 4499 | 0.310 |
Why?
|
Tunica Intima | 1 | 2011 | 459 | 0.310 |
Why?
|
Seat Belts | 1 | 2008 | 60 | 0.300 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2008 | 150 | 0.290 |
Why?
|
Muscle Contraction | 3 | 2020 | 1208 | 0.290 |
Why?
|
Femoral Vein | 2 | 2020 | 154 | 0.290 |
Why?
|
Carotid Artery, Internal | 1 | 2010 | 445 | 0.280 |
Why?
|
Cytokines | 5 | 2016 | 7445 | 0.280 |
Why?
|
Blood Vessel Prosthesis | 3 | 2022 | 957 | 0.280 |
Why?
|
Humans | 86 | 2024 | 768393 | 0.270 |
Why?
|
Angiotensin II | 4 | 2011 | 847 | 0.270 |
Why?
|
Treatment Outcome | 25 | 2024 | 65379 | 0.270 |
Why?
|
Quadriplegia | 1 | 2008 | 227 | 0.270 |
Why?
|
Laser Therapy | 1 | 2013 | 1105 | 0.260 |
Why?
|
Collagenases | 2 | 2016 | 221 | 0.250 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2012 | 703 | 0.250 |
Why?
|
Platelet-Derived Growth Factor | 2 | 2006 | 617 | 0.250 |
Why?
|
Metabolome | 1 | 2012 | 1008 | 0.240 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 692 | 0.240 |
Why?
|
Male | 56 | 2024 | 364902 | 0.240 |
Why?
|
Osteosarcoma | 1 | 2011 | 911 | 0.240 |
Why?
|
Metabolomics | 1 | 2014 | 1674 | 0.240 |
Why?
|
Signal Transduction | 7 | 2019 | 23631 | 0.230 |
Why?
|
Potassium Channels | 1 | 2007 | 538 | 0.230 |
Why?
|
Aorta, Abdominal | 2 | 2004 | 627 | 0.230 |
Why?
|
Vertebral Artery Dissection | 1 | 2004 | 48 | 0.220 |
Why?
|
Carotid Artery Diseases | 1 | 2010 | 878 | 0.220 |
Why?
|
Membrane Potentials | 3 | 2011 | 1090 | 0.220 |
Why?
|
Rats | 8 | 2019 | 23835 | 0.220 |
Why?
|
Risk Factors | 22 | 2024 | 74962 | 0.220 |
Why?
|
Cell Proliferation | 4 | 2009 | 10478 | 0.220 |
Why?
|
Inflammation | 3 | 2016 | 10863 | 0.220 |
Why?
|
U937 Cells | 2 | 2014 | 260 | 0.210 |
Why?
|
Terminology as Topic | 1 | 2010 | 1539 | 0.210 |
Why?
|
Staphylococcal Infections | 1 | 2012 | 1398 | 0.210 |
Why?
|
Abdominal Abscess | 1 | 2004 | 153 | 0.210 |
Why?
|
Cross Infection | 1 | 2012 | 1426 | 0.210 |
Why?
|
Hernia | 1 | 2003 | 68 | 0.210 |
Why?
|
Endothelial Cells | 1 | 2016 | 3587 | 0.210 |
Why?
|
Ultrasonography, Doppler, Color | 2 | 2016 | 234 | 0.200 |
Why?
|
Nitric Oxide Synthase | 3 | 2011 | 911 | 0.200 |
Why?
|
Cell Division | 5 | 2004 | 4479 | 0.200 |
Why?
|
Hospital Costs | 1 | 2008 | 959 | 0.200 |
Why?
|
Anesthesia, Local | 1 | 2024 | 279 | 0.200 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2012 | 3781 | 0.200 |
Why?
|
Lymphedema | 2 | 2022 | 527 | 0.190 |
Why?
|
Constriction, Pathologic | 2 | 2018 | 1104 | 0.190 |
Why?
|
Surgical Wound Dehiscence | 1 | 2003 | 216 | 0.190 |
Why?
|
Mutation, Missense | 1 | 2011 | 2593 | 0.190 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2024 | 692 | 0.190 |
Why?
|
Receptors, Estrogen | 1 | 2010 | 2247 | 0.190 |
Why?
|
Sclerotherapy | 2 | 2014 | 183 | 0.190 |
Why?
|
Blood Vessels | 1 | 2007 | 1110 | 0.190 |
Why?
|
Lipids | 1 | 2012 | 3344 | 0.190 |
Why?
|
Anesthesia, Conduction | 1 | 2024 | 263 | 0.180 |
Why?
|
Baroreflex | 1 | 2022 | 154 | 0.180 |
Why?
|
Laparotomy | 1 | 2003 | 459 | 0.180 |
Why?
|
Combined Modality Therapy | 2 | 2011 | 8562 | 0.180 |
Why?
|
Cyclic GMP | 2 | 2011 | 394 | 0.180 |
Why?
|
Proteomics | 1 | 2014 | 3906 | 0.180 |
Why?
|
Animals | 21 | 2020 | 169337 | 0.180 |
Why?
|
Fluid Shifts | 1 | 2020 | 20 | 0.170 |
Why?
|
Receptors, Adrenergic, alpha | 2 | 2010 | 146 | 0.170 |
Why?
|
Popliteal Artery | 1 | 2002 | 313 | 0.170 |
Why?
|
Receptor, Angiotensin, Type 1 | 2 | 2011 | 153 | 0.170 |
Why?
|
Down-Regulation | 2 | 2020 | 2940 | 0.170 |
Why?
|
Fibroblast Growth Factor 2 | 3 | 2008 | 595 | 0.170 |
Why?
|
Sarcoma | 1 | 2011 | 1807 | 0.170 |
Why?
|
Hernia, Ventral | 1 | 2003 | 220 | 0.160 |
Why?
|
P-Selectin | 1 | 2022 | 599 | 0.160 |
Why?
|
Flavonoids | 2 | 2017 | 447 | 0.160 |
Why?
|
Arteriosclerosis | 1 | 2003 | 1056 | 0.160 |
Why?
|
Potassium Channel Blockers | 2 | 2011 | 162 | 0.160 |
Why?
|
Prosthesis-Related Infections | 1 | 2004 | 494 | 0.160 |
Why?
|
Catheterization, Central Venous | 1 | 2004 | 536 | 0.160 |
Why?
|
Cardiology | 3 | 2022 | 1701 | 0.160 |
Why?
|
Peripheral Arterial Disease | 2 | 2023 | 1303 | 0.160 |
Why?
|
Arteriovenous Shunt, Surgical | 1 | 2002 | 291 | 0.160 |
Why?
|
Ischemia | 2 | 2019 | 1900 | 0.160 |
Why?
|
Macrophages | 1 | 2014 | 5796 | 0.160 |
Why?
|
MAP Kinase Signaling System | 1 | 2006 | 1493 | 0.160 |
Why?
|
Extracellular Fluid | 1 | 2020 | 165 | 0.160 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2010 | 262 | 0.150 |
Why?
|
Genomics | 1 | 2014 | 5916 | 0.150 |
Why?
|
Inflammation Mediators | 3 | 2024 | 1890 | 0.150 |
Why?
|
Middle Aged | 31 | 2024 | 223491 | 0.150 |
Why?
|
Aged | 29 | 2024 | 171562 | 0.150 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2011 | 361 | 0.150 |
Why?
|
Carotid Arteries | 1 | 2022 | 943 | 0.140 |
Why?
|
Compression Bandages | 2 | 2014 | 14 | 0.140 |
Why?
|
Postthrombotic Syndrome | 2 | 2014 | 28 | 0.140 |
Why?
|
Anesthesia, General | 1 | 2024 | 1186 | 0.140 |
Why?
|
Fatal Outcome | 2 | 2012 | 1837 | 0.140 |
Why?
|
Organ Culture Techniques | 1 | 2019 | 796 | 0.140 |
Why?
|
Aortography | 2 | 2012 | 422 | 0.140 |
Why?
|
Cell Movement | 2 | 2016 | 5215 | 0.140 |
Why?
|
Cytoskeleton | 1 | 2001 | 1176 | 0.130 |
Why?
|
Female | 38 | 2024 | 397089 | 0.130 |
Why?
|
Hemodynamics | 3 | 2017 | 4199 | 0.130 |
Why?
|
Cells, Cultured | 9 | 2024 | 19022 | 0.130 |
Why?
|
Time Factors | 13 | 2024 | 40272 | 0.130 |
Why?
|
Ligation | 1 | 2016 | 447 | 0.130 |
Why?
|
Dilatation, Pathologic | 2 | 2008 | 527 | 0.130 |
Why?
|
Stents | 4 | 2023 | 3201 | 0.130 |
Why?
|
Walking | 2 | 2020 | 1201 | 0.120 |
Why?
|
Enzyme Inhibitors | 3 | 2011 | 3722 | 0.120 |
Why?
|
Thrombolytic Therapy | 2 | 2015 | 2050 | 0.120 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 463 | 0.120 |
Why?
|
Veterans Health | 1 | 2016 | 215 | 0.120 |
Why?
|
Postoperative Complications | 7 | 2024 | 15881 | 0.120 |
Why?
|
Actins | 1 | 2001 | 2059 | 0.110 |
Why?
|
Cell Differentiation | 1 | 2011 | 11668 | 0.110 |
Why?
|
Predictive Value of Tests | 6 | 2019 | 15455 | 0.110 |
Why?
|
Choice Behavior | 1 | 2019 | 848 | 0.110 |
Why?
|
Spine | 1 | 2020 | 1141 | 0.110 |
Why?
|
Immunohistochemistry | 4 | 2011 | 11120 | 0.100 |
Why?
|
Prostaglandins I | 1 | 2011 | 12 | 0.100 |
Why?
|
Probability | 3 | 2010 | 2482 | 0.100 |
Why?
|
Diosmin | 1 | 2011 | 6 | 0.100 |
Why?
|
Adrenergic alpha-1 Receptor Agonists | 1 | 2011 | 18 | 0.100 |
Why?
|
Immunosuppressive Agents | 1 | 2004 | 4209 | 0.090 |
Why?
|
Tuberculosis | 1 | 2004 | 2029 | 0.090 |
Why?
|
Patient Preference | 1 | 2019 | 947 | 0.090 |
Why?
|
Receptors, Adrenergic, alpha-1 | 1 | 2011 | 42 | 0.090 |
Why?
|
Chi-Square Distribution | 3 | 2016 | 3438 | 0.090 |
Why?
|
Tomography, X-Ray Computed | 7 | 2012 | 20765 | 0.090 |
Why?
|
Oxidoreductases, N-Demethylating | 1 | 2011 | 109 | 0.090 |
Why?
|
Isometric Contraction | 2 | 2008 | 150 | 0.090 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2014 | 631 | 0.090 |
Why?
|
Pressoreceptors | 1 | 2010 | 99 | 0.090 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1364 | 0.090 |
Why?
|
Risk Assessment | 11 | 2024 | 24318 | 0.090 |
Why?
|
Observer Variation | 1 | 2017 | 2623 | 0.090 |
Why?
|
Evidence-Based Medicine | 4 | 2015 | 3707 | 0.090 |
Why?
|
Body Composition | 1 | 2020 | 2461 | 0.090 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 892 | 0.090 |
Why?
|
Prognosis | 5 | 2019 | 30022 | 0.090 |
Why?
|
Apoptosis | 2 | 2008 | 9516 | 0.080 |
Why?
|
Receptors, Angiotensin | 1 | 2010 | 141 | 0.080 |
Why?
|
Prospective Studies | 9 | 2020 | 54920 | 0.080 |
Why?
|
Estrogen Antagonists | 1 | 2010 | 150 | 0.080 |
Why?
|
Logistic Models | 5 | 2023 | 13323 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 2003 | 0.080 |
Why?
|
Chemokines | 1 | 2014 | 962 | 0.080 |
Why?
|
Resistin | 1 | 2010 | 172 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18048 | 0.080 |
Why?
|
Estrogen Receptor beta | 1 | 2010 | 171 | 0.080 |
Why?
|
Sodium Chloride, Dietary | 1 | 2011 | 301 | 0.080 |
Why?
|
Thrombectomy | 2 | 2012 | 671 | 0.080 |
Why?
|
Decision Support Techniques | 1 | 2019 | 2006 | 0.080 |
Why?
|
Nitric Oxide Synthase Type III | 2 | 2011 | 706 | 0.080 |
Why?
|
Autopsy | 1 | 2012 | 1013 | 0.080 |
Why?
|
Vascular Patency | 1 | 2011 | 916 | 0.080 |
Why?
|
Prosthesis Design | 2 | 2022 | 2126 | 0.080 |
Why?
|
Nitriles | 2 | 2010 | 984 | 0.070 |
Why?
|
Wheelchairs | 1 | 2008 | 78 | 0.070 |
Why?
|
Acetylcholine | 1 | 2010 | 629 | 0.070 |
Why?
|
Reference Values | 2 | 2008 | 4941 | 0.070 |
Why?
|
Adult | 17 | 2024 | 223640 | 0.070 |
Why?
|
Scleroderma, Localized | 1 | 2008 | 85 | 0.070 |
Why?
|
Poisson Distribution | 1 | 2008 | 509 | 0.070 |
Why?
|
Cromakalim | 1 | 2007 | 23 | 0.070 |
Why?
|
Potassium Channels, Calcium-Activated | 1 | 2007 | 43 | 0.070 |
Why?
|
Odds Ratio | 5 | 2022 | 9682 | 0.070 |
Why?
|
Large-Conductance Calcium-Activated Potassium Channel alpha Subunits | 1 | 2007 | 21 | 0.070 |
Why?
|
Tissue Culture Techniques | 1 | 2008 | 290 | 0.070 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 245 | 0.070 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 623 | 0.070 |
Why?
|
Hospital Charges | 1 | 2008 | 351 | 0.070 |
Why?
|
Biopsy | 2 | 2011 | 6808 | 0.070 |
Why?
|
Indomethacin | 1 | 2007 | 323 | 0.070 |
Why?
|
Acute Disease | 3 | 2012 | 7242 | 0.070 |
Why?
|
Hyperemia | 1 | 2007 | 224 | 0.070 |
Why?
|
Caveolin 1 | 1 | 2008 | 255 | 0.070 |
Why?
|
Phenols | 1 | 2010 | 520 | 0.070 |
Why?
|
Lipopolysaccharides | 1 | 2014 | 2215 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2024 | 81801 | 0.060 |
Why?
|
Case-Control Studies | 2 | 2017 | 22296 | 0.060 |
Why?
|
Epoprostenol | 1 | 2007 | 246 | 0.060 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 3813 | 0.060 |
Why?
|
Estrogen Receptor alpha | 1 | 2010 | 581 | 0.060 |
Why?
|
Brachial Artery | 1 | 2007 | 373 | 0.060 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1658 | 0.060 |
Why?
|
Mechanotransduction, Cellular | 1 | 2010 | 542 | 0.060 |
Why?
|
Radiotherapy, Adjuvant | 1 | 2011 | 1794 | 0.060 |
Why?
|
Exudates and Transudates | 1 | 2006 | 175 | 0.060 |
Why?
|
Tuberculosis, Cardiovascular | 1 | 2004 | 8 | 0.060 |
Why?
|
Incidental Findings | 1 | 2010 | 698 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 379 | 0.060 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2009 | 637 | 0.060 |
Why?
|
Immunoblotting | 1 | 2008 | 1647 | 0.060 |
Why?
|
Leukemia | 1 | 2013 | 1526 | 0.060 |
Why?
|
Collagen | 1 | 2013 | 2646 | 0.060 |
Why?
|
Pressure | 1 | 2008 | 1172 | 0.060 |
Why?
|
Protease Inhibitors | 1 | 2008 | 752 | 0.060 |
Why?
|
Rifabutin | 1 | 2004 | 59 | 0.060 |
Why?
|
Thigh | 1 | 2006 | 239 | 0.060 |
Why?
|
Coronary Restenosis | 1 | 2007 | 396 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2019 | 4047 | 0.060 |
Why?
|
Interleukin-1 | 1 | 2008 | 1251 | 0.060 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2010 | 1141 | 0.060 |
Why?
|
Age Factors | 3 | 2017 | 18471 | 0.060 |
Why?
|
Sodium, Dietary | 1 | 2008 | 426 | 0.060 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2006 | 331 | 0.060 |
Why?
|
Adiponectin | 1 | 2010 | 1117 | 0.060 |
Why?
|
Magnetic Resonance Angiography | 1 | 2011 | 1434 | 0.060 |
Why?
|
Popliteal Vein | 1 | 2023 | 43 | 0.060 |
Why?
|
Random Allocation | 1 | 2008 | 2397 | 0.050 |
Why?
|
Diagnostic Errors | 1 | 2011 | 1280 | 0.050 |
Why?
|
Aged, 80 and over | 8 | 2024 | 59686 | 0.050 |
Why?
|
Receptors, Growth Factor | 1 | 2004 | 326 | 0.050 |
Why?
|
Severity of Illness Index | 4 | 2011 | 15939 | 0.050 |
Why?
|
Aortic Aneurysm | 1 | 2008 | 649 | 0.050 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2006 | 615 | 0.050 |
Why?
|
Estrogens | 1 | 2010 | 1534 | 0.050 |
Why?
|
Takayasu Arteritis | 1 | 2004 | 105 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2010 | 1315 | 0.050 |
Why?
|
Oligopeptides | 1 | 2008 | 1194 | 0.050 |
Why?
|
Jugular Veins | 1 | 2004 | 211 | 0.050 |
Why?
|
Vascular Fistula | 1 | 2003 | 50 | 0.050 |
Why?
|
Up-Regulation | 2 | 2010 | 4142 | 0.050 |
Why?
|
Isoniazid | 1 | 2004 | 288 | 0.050 |
Why?
|
Societies, Medical | 2 | 2014 | 3960 | 0.050 |
Why?
|
Estradiol | 1 | 2010 | 1952 | 0.050 |
Why?
|
Prosthesis Failure | 1 | 2008 | 1208 | 0.050 |
Why?
|
Duodenal Diseases | 1 | 2003 | 101 | 0.050 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2019 | 10377 | 0.050 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2010 | 1248 | 0.050 |
Why?
|
Retinoblastoma Protein | 1 | 2006 | 673 | 0.050 |
Why?
|
Fibrinolytic Agents | 1 | 2012 | 2074 | 0.050 |
Why?
|
Tibial Arteries | 1 | 2002 | 60 | 0.050 |
Why?
|
Polyethylene Terephthalates | 1 | 2002 | 112 | 0.050 |
Why?
|
Imidazoles | 1 | 2008 | 1168 | 0.050 |
Why?
|
Intestinal Fistula | 1 | 2003 | 144 | 0.050 |
Why?
|
Hypertension | 3 | 2017 | 8615 | 0.050 |
Why?
|
Sensitivity and Specificity | 3 | 2010 | 14737 | 0.050 |
Why?
|
Debridement | 1 | 2004 | 492 | 0.050 |
Why?
|
Endoleak | 1 | 2022 | 111 | 0.050 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2587 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2009 | 1739 | 0.050 |
Why?
|
Regional Blood Flow | 2 | 2019 | 1502 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 2 | 2008 | 5708 | 0.040 |
Why?
|
Radiography | 1 | 2011 | 6993 | 0.040 |
Why?
|
Quality Improvement | 1 | 2015 | 3858 | 0.040 |
Why?
|
von Willebrand Factor | 1 | 2024 | 680 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2014 | 3541 | 0.040 |
Why?
|
Neovascularization, Physiologic | 1 | 2007 | 1371 | 0.040 |
Why?
|
Disease Progression | 2 | 2012 | 13646 | 0.040 |
Why?
|
Phosphorylation | 2 | 2008 | 8326 | 0.040 |
Why?
|
Patient Selection | 3 | 2022 | 4266 | 0.040 |
Why?
|
Fibronectins | 2 | 2003 | 724 | 0.040 |
Why?
|
Length of Stay | 2 | 2016 | 6519 | 0.040 |
Why?
|
Health Care Costs | 1 | 2013 | 3267 | 0.040 |
Why?
|
Pyrazoles | 1 | 2010 | 2021 | 0.040 |
Why?
|
Extracellular Space | 1 | 2001 | 565 | 0.040 |
Why?
|
Administration, Topical | 1 | 2021 | 703 | 0.040 |
Why?
|
Device Removal | 1 | 2004 | 643 | 0.040 |
Why?
|
Diagnosis, Differential | 1 | 2014 | 13020 | 0.040 |
Why?
|
Least-Squares Analysis | 1 | 1999 | 368 | 0.040 |
Why?
|
Drainage | 1 | 2004 | 1184 | 0.040 |
Why?
|
Linear Models | 1 | 2008 | 5878 | 0.040 |
Why?
|
Blotting, Western | 3 | 2011 | 5037 | 0.040 |
Why?
|
beta-Galactosidase | 1 | 1999 | 575 | 0.040 |
Why?
|
Blood Pressure | 2 | 2011 | 8541 | 0.040 |
Why?
|
Physicians | 1 | 2016 | 4614 | 0.040 |
Why?
|
Information Seeking Behavior | 1 | 2019 | 116 | 0.040 |
Why?
|
Propensity Score | 2 | 2016 | 1962 | 0.040 |
Why?
|
Dyslipidemias | 1 | 2005 | 873 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 888 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2002 | 592 | 0.040 |
Why?
|
Pericardium | 1 | 2002 | 679 | 0.040 |
Why?
|
Streptonigrin | 1 | 1997 | 1 | 0.040 |
Why?
|
Pre-Eclampsia | 1 | 2007 | 1255 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 15872 | 0.030 |
Why?
|
Breast Neoplasms, Male | 1 | 1999 | 212 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2008 | 4357 | 0.030 |
Why?
|
Blood Loss, Surgical | 2 | 2016 | 643 | 0.030 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12092 | 0.030 |
Why?
|
Pyridines | 1 | 2008 | 2889 | 0.030 |
Why?
|
Biopsy, Needle | 1 | 2001 | 1627 | 0.030 |
Why?
|
Sex Factors | 1 | 2010 | 10654 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2004 | 1391 | 0.030 |
Why?
|
Cell Death | 1 | 2001 | 1682 | 0.030 |
Why?
|
Palliative Care | 1 | 2011 | 3643 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2001 | 2862 | 0.030 |
Why?
|
Electric Impedance | 1 | 2020 | 795 | 0.030 |
Why?
|
Permeability | 1 | 2017 | 726 | 0.030 |
Why?
|
Peptides | 1 | 2007 | 4353 | 0.030 |
Why?
|
United States | 6 | 2022 | 73150 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2024 | 3230 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2019 | 1727 | 0.030 |
Why?
|
Follow-Up Studies | 4 | 2015 | 39407 | 0.030 |
Why?
|
Capillaries | 1 | 2017 | 756 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2012 | 7463 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 1 | 2004 | 1929 | 0.030 |
Why?
|
Antibiotics, Antineoplastic | 1 | 1997 | 677 | 0.030 |
Why?
|
Diagnostic Techniques, Cardiovascular | 1 | 2014 | 153 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2005 | 2491 | 0.030 |
Why?
|
Edema | 1 | 2017 | 766 | 0.030 |
Why?
|
Young Adult | 2 | 2017 | 60049 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2017 | 1703 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2019 | 2106 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2011 | 18362 | 0.030 |
Why?
|
Pneumonia | 1 | 2004 | 2163 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4588 | 0.020 |
Why?
|
Consensus | 1 | 2022 | 3212 | 0.020 |
Why?
|
Echinomycin | 1 | 2010 | 2 | 0.020 |
Why?
|
Atherosclerosis | 1 | 2007 | 3431 | 0.020 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1680 | 0.020 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 940 | 0.020 |
Why?
|
Cell Cycle | 1 | 1999 | 2938 | 0.020 |
Why?
|
Butadienes | 1 | 2010 | 107 | 0.020 |
Why?
|
Analysis of Variance | 1 | 1999 | 6241 | 0.020 |
Why?
|
Guanylate Cyclase | 1 | 2011 | 206 | 0.020 |
Why?
|
Databases, Factual | 2 | 2016 | 8075 | 0.020 |
Why?
|
Benzoquinones | 1 | 2010 | 198 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2004 | 3243 | 0.020 |
Why?
|
Renin | 1 | 2011 | 648 | 0.020 |
Why?
|
Lactams, Macrocyclic | 1 | 2010 | 319 | 0.020 |
Why?
|
Thrombosis | 1 | 2003 | 2955 | 0.020 |
Why?
|
Histone Demethylases | 1 | 2011 | 322 | 0.020 |
Why?
|
Smoking | 1 | 2005 | 9111 | 0.020 |
Why?
|
Adipokines | 1 | 2010 | 309 | 0.020 |
Why?
|
Muscle Relaxation | 1 | 2008 | 138 | 0.020 |
Why?
|
Self Report | 1 | 2019 | 3766 | 0.020 |
Why?
|
Molecular Weight | 1 | 2010 | 2172 | 0.020 |
Why?
|
Program Evaluation | 1 | 2015 | 2505 | 0.020 |
Why?
|
Algorithms | 2 | 2005 | 14154 | 0.020 |
Why?
|
Aldosterone | 1 | 2011 | 881 | 0.020 |
Why?
|
Cyclin D | 1 | 2006 | 72 | 0.020 |
Why?
|
Reoperation | 1 | 2016 | 4341 | 0.020 |
Why?
|
Lung Neoplasms | 1 | 2010 | 13576 | 0.020 |
Why?
|
Pregnancy | 1 | 2007 | 30200 | 0.020 |
Why?
|
Aorta, Thoracic | 1 | 2011 | 1112 | 0.010 |
Why?
|
Transplantation, Autologous | 1 | 2010 | 2127 | 0.010 |
Why?
|
Angiography | 1 | 2010 | 1598 | 0.010 |
Why?
|
Models, Statistical | 1 | 2019 | 5099 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2010 | 2931 | 0.010 |
Why?
|
RNA, Messenger | 2 | 2010 | 12805 | 0.010 |
Why?
|
Mice, Knockout | 2 | 2011 | 14481 | 0.010 |
Why?
|
Proportional Hazards Models | 2 | 2010 | 12558 | 0.010 |
Why?
|
Aging | 1 | 2003 | 8764 | 0.010 |
Why?
|
Cyclins | 1 | 2006 | 606 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2007 | 1376 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15597 | 0.010 |
Why?
|
Hematemesis | 1 | 2003 | 22 | 0.010 |
Why?
|
Patient Discharge | 1 | 2016 | 3476 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5367 | 0.010 |
Why?
|
Cardiovascular Diseases | 1 | 2007 | 15649 | 0.010 |
Why?
|
Comorbidity | 1 | 2016 | 10588 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2001 | 26411 | 0.010 |
Why?
|
Surgical Mesh | 1 | 2002 | 316 | 0.010 |
Why?
|
Graft Survival | 1 | 2010 | 3900 | 0.010 |
Why?
|
Anastomosis, Surgical | 1 | 2002 | 993 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26375 | 0.010 |
Why?
|
Recurrence | 1 | 2011 | 8506 | 0.010 |
Why?
|
Electron Spin Resonance Spectroscopy | 1 | 1997 | 161 | 0.010 |
Why?
|
Body Weight | 1 | 2008 | 4629 | 0.010 |
Why?
|
Methanol | 1 | 1997 | 91 | 0.010 |
Why?
|
Genotype | 1 | 2011 | 13042 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2007 | 6541 | 0.010 |
Why?
|
Drug Stability | 1 | 1997 | 291 | 0.010 |
Why?
|
Solutions | 1 | 1997 | 409 | 0.010 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2003 | 709 | 0.010 |
Why?
|
Dimethyl Sulfoxide | 1 | 1997 | 251 | 0.010 |
Why?
|
Solvents | 1 | 1997 | 298 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13503 | 0.010 |
Why?
|
Ultrasonography | 1 | 2007 | 6001 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 14784 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16721 | 0.010 |
Why?
|
Mice | 2 | 2011 | 82017 | 0.010 |
Why?
|
Hydrogen-Ion Concentration | 1 | 1997 | 2488 | 0.010 |
Why?
|
Structure-Activity Relationship | 1 | 1997 | 3055 | 0.010 |
Why?
|
Temperature | 1 | 1997 | 2235 | 0.010 |
Why?
|
Diet | 1 | 2008 | 8090 | 0.010 |
Why?
|
Indoles | 1 | 1997 | 1825 | 0.000 |
Why?
|
Incidence | 1 | 1999 | 21544 | 0.000 |
Why?
|